Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neutropenia|Febrile Neutropenia
Interventions: DRUG: Filgrastim|DRUG: Peg-filgrastim
Sponsor: Asan Medical Center
Collaborators: Kyowa Kirin Co., Ltd.